549 related articles for article (PubMed ID: 26834515)
1. The Current and Future Therapies for Human Osteosarcoma.
Lamplot JD; Denduluri S; Qin J; Li R; Liu X; Zhang H; Chen X; Wang N; Pratt A; Shui W; Luo X; Nan G; Deng ZL; Luo J; Haydon RC; He TC; Luu HH
Curr Cancer Ther Rev; 2013 Feb; 9(1):55-77. PubMed ID: 26834515
[TBL] [Abstract][Full Text] [Related]
2. Role of TKI for Metastatic Osteogenic Sarcoma.
Duffaud F
Curr Treat Options Oncol; 2020 Jun; 21(8):65. PubMed ID: 32601895
[TBL] [Abstract][Full Text] [Related]
3. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
4. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and therapies for metastatic sarcoma.
Amankwah EK; Conley AP; Reed DR
Clin Epidemiol; 2013; 5():147-62. PubMed ID: 23700373
[TBL] [Abstract][Full Text] [Related]
6. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
7. Advances in emerging drugs for osteosarcoma.
Hattinger CM; Fanelli M; Tavanti E; Vella S; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2015 Sep; 20(3):495-514. PubMed ID: 26021401
[TBL] [Abstract][Full Text] [Related]
8. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
9. Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma).
Anderson P; Kopp L; Anderson N; Cornelius K; Herzog C; Hughes D; Huh W
Expert Opin Investig Drugs; 2008 Nov; 17(11):1703-15. PubMed ID: 18922107
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate Free Chemotherapy and Limb Salvage Surgery for Paediatric Osteosarcoma in India.
Sukumaran RK; Rajeshwari B; Sugath S; Chellappan SG; Thankamony P; Parukuttyamma K
Indian J Orthop; 2018; 52(1):58-64. PubMed ID: 29416171
[TBL] [Abstract][Full Text] [Related]
11. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
12. Innovative approaches for treatment of osteosarcoma.
Rothzerg E; Pfaff AL; Koks S
Exp Biol Med (Maywood); 2022 Feb; 247(4):310-316. PubMed ID: 35043695
[TBL] [Abstract][Full Text] [Related]
13. Animal models in osteosarcoma.
Guijarro MV; Ghivizzani SC; Gibbs CP
Front Oncol; 2014; 4():189. PubMed ID: 25101245
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma: mouse models, cell of origin and cancer stem cell.
Guijarro MV
Postdoc J; 2014 Feb; 2(2):19-30. PubMed ID: 27617267
[TBL] [Abstract][Full Text] [Related]
16. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
Marchandet L; Lallier M; Charrier C; Baud'huin M; Ory B; Lamoureux F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567616
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.
Abarrategi A; Tornin J; Martinez-Cruzado L; Hamilton A; Martinez-Campos E; Rodrigo JP; González MV; Baldini N; Garcia-Castro J; Rodriguez R
Stem Cells Int; 2016; 2016():3631764. PubMed ID: 27366153
[TBL] [Abstract][Full Text] [Related]
19. Modeling human osteosarcoma in the mouse: From bedside to bench.
Janeway KA; Walkley CR
Bone; 2010 Nov; 47(5):859-65. PubMed ID: 20696288
[TBL] [Abstract][Full Text] [Related]
20. Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis.
Papakonstantinou E; Stamatopoulos A; I Athanasiadis D; Kenanidis E; Potoupnis M; Haidich AB; Tsiridis E
J Bone Oncol; 2020 Dec; 25():100319. PubMed ID: 33088699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
